C反应蛋白与白蛋白比值对发热伴血小板减少综合征患者的预后意义
Prognostic Significance of the C-Reactive Protein to Albumin Ratio in Patients with Fever with Thrombocytopenia Syndrome
DOI: 10.12677/ACM.2023.1371605, PDF,   
作者: 陈 冲, 张照如*:安徽医科大学附属巢湖医院感染科,安徽 合肥
关键词: 发热伴血小板减少综合征C反应蛋白与白蛋白比值危险因素临床预后SFTS CAR Risk Factors Clinical Prognosis
摘要: 目的:我们的研究是为了探索影响发热伴血小板减少综合征(SFTS)预后不良的危险因素,并探讨以炎症为基础的比值指标在SFTS患者中的预测意义。方法:回顾性收集2019年6月至2023年4月从安徽医科大学附属巢湖医院共纳入了152例SFTS病毒RNA阳性的确诊患者。根据患者治疗后是否存活将患者分为两组,生存组124例和死亡组28例。收集患者刚入院时第一次的采血数据,利用多因素logistic回归分析SFTS患者进展至死亡的独立危险因素。采用ROC曲线分析来评估NLR、CAR在识别SFTS患者预后不良的预测准确性。结果:多因素logistic回归分析发现年龄大、有出血表现、APTT延长和CAR是影响SFTS患者预后的危险因素,ROC曲线分析表明:CAR的AUC为0.770 (95%CI: 0.689~0.851; P < 0.001)。CAR的最佳截断值断值是0.1,灵敏性和特异性分别为82.1%和65.5%。结论:年龄大、有出血症状、APTT延长以及CAR高水平是SFTS患者死亡的重要危险因素,而较高的CAR可能会对预测SFTS患者的疾病进展与临床预后有一定的参考价值。
Abstract: Objective: Our study was intended to investigate the risk factors contributing to the poor prognosis of patients with fever with thrombocytopenia syndrome (SFTS) and the predictive value of inflam-mation-based ratio indicators in these patients. Methods: A total of 152 confirmed patients with positive SFTS virus RNA were retrospectively collected from June 2019 to April 2023 from Chaohu Hospital, Anhui Medical University. Patients were divided into two groups according to whether they survived after treatment, 124 in the survival group and 28 in the death group. Data from the first blood collection when the patients were first admitted to the hospital were collected, and in-dependent risk factors for progression to death in SFTS patients were analyzed using multivariate logistic regression. ROC curve analysis was used to assess the predictive accuracy of NLR, CAR in identifying SFTS patients with poor prognosis. Results: Multivariate logistic regression analysis identified older age, presence of bleeding manifestations, prolonged APTT and CAR as risk factors affecting the prognosis of SFTS patients, and ROC curve analysis showed that the AUC for CAR was 0.770 (95%CI: 0.689~0.851; P < 0.001). The optimal cut-off value for CAR was 0.1, with a sensitivity and specificity of 82.1% and 65.5%, respectively. Conclusion: Older age, presence of bleeding symptoms, prolonged APTT, and high levels of CAR are important risk factors for death in SFTS pa-tients, and higher CAR may be informative in predicting disease progression and clinical prognosis in SFTS patients.
文章引用:陈冲, 张照如. C反应蛋白与白蛋白比值对发热伴血小板减少综合征患者的预后意义[J]. 临床医学进展, 2023, 13(7): 11484-11491. https://doi.org/10.12677/ACM.2023.1371605

参考文献

[1] Yu, X.J., Liang, M.F., Zhang, S.Y., et al. (2011) Fever with Thrombocytopenia Associated with a Novel Bunyavirus in China. The New England Journal of Medicine, 364, 1523-1532. [Google Scholar] [CrossRef
[2] Kim, K.H., Yi, J., Kim, G., et al. (2013) Severe Fever with Thrombocytopenia Syndrome, South Korea, 2012. Emerging Infec-tious Diseases, 19, 1892-1894. [Google Scholar] [CrossRef] [PubMed]
[3] Takahashi, T., Maeda, K., Suzuki, T., et al. (2014) The First Identification and Retrospective Study of Severe Fever with Thrombocytopenia Syndrome in Japan. The Journal of Infectious Diseases, 209, 816-827. [Google Scholar] [CrossRef] [PubMed]
[4] Tran, X.C., Yun, Y., Van An, L., et al. (2019) Endemic Severe Fever with Thrombocytopenia Syndrome, Vietnam. Emer- ging Infectious Diseases, 25, 1029-1031. [Google Scholar] [CrossRef] [PubMed]
[5] Li, J., Li, S., Yang, L., et al. (2021) Severe Fever with Thrombocyto-penia Syndrome Virus: A Highly Lethal Bunyavirus. Critical Reviews in Microbiology, 47, 112-125. [Google Scholar] [CrossRef
[6] Sun, L., Hu, Y., Niyonsaba, A., et al. (2014) Detection and Evaluation of Immune Function of Patients with Severe Fever with Thrombocytopenia Syndrome. Clinical and Experi-mental Medicine, 14, 389-395. [Google Scholar] [CrossRef] [PubMed]
[7] Park, A., Park, S.J., Jung, K.L., et al. (2021) Molecular Signa-tures of Inflammatory Profile and B-Cell Function in Patients with Severe Fever with Thrombocytopenia Syndrome. mBio, 12, e02583-20. [Google Scholar] [CrossRef
[8] 李宛成, 姜文凯, 朱伟雄, 等. 术前中性粒细胞与淋巴细胞比值对胰腺癌手术患者预后价值的Meta分析[J]. 中国普通外科杂志, 2023, 32(3): 346-356.
[9] 张绍谨, 闫泽晨, 李腾, 等. 外周血血小板计数与淋巴细胞计数比值对心肾综合征预后的预测价值[J]. 郑州大学学报(医学版), 2023, 58(2): 213-217.
[10] Huang, Z., Zheng, Q., Yu, Y., et al. (2022) Prognostic Significance of Platelet-to-Albumin Ratio in Patients with Esophageal Squamous Cell Carcinoma Receiving Definitive Radiotherapy. Scientific Reports, 12, Article No. 3535. [Google Scholar] [CrossRef] [PubMed]
[11] 王锴, 郭向婷, 宗守凯. C反应蛋白/白蛋白、血小板/淋巴细胞比率与乳腺癌患者病理特征、新辅助化疗疗效的相关性[J]. 川北医学院学报, 2022, 37(8): 1032-1036.
[12] 陈广, 陈韬, 舒赛男, 等. 重症发热伴血小板减少综合征诊治专家共识[J]. 传染病信息, 2022, 35(5): 385-393.
[13] 倪秀莹, 孙朝霞, 程素洁, 等. 血管紧张素Ⅱ和C反应蛋白对发热伴血小板减少综合征的早期诊断及预后评估价值研究[J]. 广东医学, 2017, 38(11): 1699-1702.
[14] Xu, X., Sun, Z., Liu, J., et al. (2018) Analysis of Clinical Fea-tures and Early Warning Indicators of Death from Severe Fever with Thrombocytopenia Syndrome. International Jour-nal of Infectious Diseases, 73, 43-48. [Google Scholar] [CrossRef] [PubMed]
[15] Arroyo, V., García‐Martinez, R. and Salvatella, X. (2014) Human Serum Albumin, Systemic Inflammation, and Cirrhosis. Journal of Hepatology, 61, 396‐407. [Google Scholar] [CrossRef] [PubMed]
[16] Liao, C.K., Yu, Y.L., Lin, Y.C., et al. (2021) Prognostic Value of the C-Reactive Protein to Albumin Ratio in Colorectal Cancer: An Updated Systematic Review and Meta-Analysis. World Journal of Surgical Oncology, 19, Article No. 139. [Google Scholar] [CrossRef] [PubMed]
[17] Bao, Y., Yang, J., Duan, Y., et al. (2021) The C-Reactive Protein to Albumin Ratio Is an Excellent Prognostic Predictor for Gallbladder Cancer. BioScience Trends, 14, 428-435. [Google Scholar] [CrossRef] [PubMed]
[18] Xu, T., Xia, L., Wu, Y., et al. (2023) High Ratio of C-Reactive Protein to Albumin Is Associated with Hemorrhagic Transformation and Poor Functional Outcomes in Acute Ischemic Stroke Patients after Thrombolysis. Frontiers in Aging Neuroscience, 15, Article ID: 1109144. [Google Scholar] [CrossRef] [PubMed]
[19] Li, H., Lu, Q.B., Xing, B., et al. (2018) Ep-idemiological and Clinical Features of Laboratory-Diagnosed Severe Fever with Thrombocytopenia Syndrome in China, 2011-17: A Prospective Observational Study. The Lancet Infectious Diseases, 18, 1127-1137. [Google Scholar] [CrossRef
[20] Song, L., Zhao, Y., Wang, G., et al. (2022) Analysis of Risk Factors Associated with Fatal Outcome among Severe Fever with Thrombocytopenia Syndrome Patients from 2015 to 2019 in Shandong, China. European Journal of Clinical Microbiology & Infectious Diseases, 41, 1415-1420. [Google Scholar] [CrossRef] [PubMed]
[21] 徐玲, 王华, 梁博云, 等. 发热伴血小板减少综合征凝血功能异常的临床特征及意义[J]. 中华内科杂志, 2022, 61(7): 793-796.
[22] Wang, Y., Song, Z., Xu, X., et al. (2022) Clinical Symptoms Associated with Fatality of Severe Fever with Thrombocytopenia Syndrome: A Systematic Review and Meta-Analysis. Acta Tropica, 232, Article ID: 106481. [Google Scholar] [CrossRef] [PubMed]
[23] Li, X.K., Yang, Z.D., Du, J., et al. (2017) Endothelial Acti-vation and Dysfunction in Severe Fever with Thrombocytopenia Syndrome. PLOS Neglected Tropical Diseases, 11, e0005746. [Google Scholar] [CrossRef] [PubMed]
[24] 李爽, 程波, 王强, 等. 血小板与内皮细胞屏障功能[J]. 中华危重症医学杂志: 电子版, 2019, 12(1): 56-60.